Author: Customer Service

 — Launch follows MHLW approval of IMCIVREE for acquired hypothalamic obesity and inclusion on Japan’s National Health Insurance drug price list — — IMCIVREE is the first approved therapy in Japan for patients living with acquired hypothalamic obesity — BOSTON, Oct. 13, 2026 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced the commercial launch of IMCIVREE® (setmelanotide) in Japan to treat patients living with acquired hypothalamic obesity (HO), following its inclusion on Japan’s National Health Insurance (NHI) drug price list. IMCIVREE is the first approved therapy in Japan for acquired HO. “This launch marks an important...

Brand Vision, Two Flagships and Global Strategy Take the Stage in Wuhu, China WUHU, China, Oct. 13, 2026 (GLOBE NEWSWIRE) — On October 21, the LUXEED Global Brand Launch will take center stage at Shenshan Zhigu, Wuhu, Anhui, China. Held under the theme “INTELLIGENCE, ENLIGHTENED,” the event will bring together the brand’s core identity, avant-garde design language, product prowess, and global strategy—presenting in full LUXEED’s vision and brand identity for the global market. As intelligent technology advances at an unprecedented pace, the very benchmarks of luxury are being rewritten. Today’s Pioneers with Power refuse to compromise among Extreme Driving Pleasure, Beyond-Class Enjoyment and Ultimate Intelligence—expecting all three to be delivered as one seamless, holistic mobility experience. On October 21, LUXEED will set out...

BOSTON and DAEJEON, South Korea, Oct. 13, 2026 (GLOBE NEWSWIRE) — Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced that the first patient has been dosed in a Phase 1 clinical trial evaluating ORM-1153, the Company’s investigational CD123-GSPT1 DAC, in patients with relapsed or refractory acute myeloid leukemia (AML) and other CD123-expressing hematologic malignancies. ORM-1153 combines Orum’s internally developed CD123-targeting antibody with a proprietary GSPT1 degrader payload. The antibody was engineered for efficient internalization into target cells and reduced Fc-gamma receptor interactions, with a linker designed for plasma stability. Preclinical studies demonstrated activity across primary AML patient samples and...

NEWPORT NEWS, Va., Oct. 13, 2026 (GLOBE NEWSWIRE) — HII (NYSE: HII) announced today that its Newport News Shipbuilding (NNS) division was awarded a $56 million contract by the U.S. Navy for shipbuilding engineering and design in support of the trilateral Australia, United Kingdom, and United States (AUKUS) partnership. The contract includes an option which, if exercised, would bring the cumulative value of this contract to $91 million. HII continues to take a whole-company approach to support the AUKUS agreement, providing services and support for AUKUS across its business divisions. Under the contract, in support of Foreign Military Sales (FMS) requirements, NNS will continue supporting the United Kingdom and Australia, including technology insertion, engineering, supply chain and workforce development support, and digital transformation....

RANCHO CORDOVA, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) — Five Star Bancorp (Nasdaq: FSBC) (“Five Star” or the “Company”), a holding company that operates through its wholly owned banking subsidiary, Five Star Bank (the “Bank”), expects to report its financial results for the quarter ended September 30, 2026, after the stock market closes on Monday, October 26, 2026. Management will host a live webcast for analysts and investors to review this information at 1:00 PM ET (10:00 AM PT) on October 27, 2026. The live webcast will be accessible from the “News & Events” section of the Company’s website under “Events” at https://investors.fivestarbank.com/news-events/events. Please pre-register for the event using this link. The webcast will be archived on the Company’s website for a period of 90 days. About Five Star BancorpFive Star...

Presentation to highlight established logistics operations and growth strategy spanning AI-powered digital entertainment and live events PERTH, Australia, Oct. 13, 2026 (GLOBE NEWSWIRE) — via IBN — Globavend Holdings Limited (NASDAQ: GVH) (“Globavend” or the “Company”), an emerging e-commerce logistics provider and AI-powered digital entertainment company, today announced that its Chairman, Kenny K.M. Fung, will present at the 2026 ThinkEquity Conference on Thursday, October 15, 2026, at the Mandarin Oriental Hotel in New York City. Mr. Fung will provide an overview of Globavend’s business, recent developments and growth strategy, highlighting the Company’s established cross-border logistics operations alongside its expansion into digital and live entertainment through Loomi Entertainment Group Limited. The presentation will...

HALIFAX, Nova Scotia, Oct. 13, 2026 (GLOBE NEWSWIRE) — Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN; OTCQX: ERDCF) (“Erdene” or the “Company”) announces that it will release the results of the Preliminary Economic Assessment (“PEA”) of its Zuun Mod Molybdenum-Copper Project on October 14, 2026, after market hours.  Management will host a conference call and webcast to discuss the results, on Thursday October 15, 2026, at 9:00 AM Eastern Time. The dial-in numbers for the conference call are as follows:North America (toll free): 1 800 717 1738 Overseas or local (Toronto): 1 289 514 5100The webcast will be accessible at the following link: HERE A replay of the webcast will be available at the same link for one year after the event. About Erdene Erdene Resource Development Corp. is a Canada-based...